Documentation: independent COA with HPLC purity and identity confirmation · Verify COA
GLP-1/glucagon dual receptor agonist for hepatic metabolism and energy research. ≥98% purity, COA. RUO only.
Volume savings — order more, pay less per vial
| Qty | Price / vial | Saving |
|---|---|---|
| 1 vial | List price | — |
| 3 vials | −10% | Save 10% |
| 5 vials | −15% | Save 15% |
| 10 vials Best value | −20% | Save 20% |
Volume tiers apply at checkout when configured for this SKU.
Frequently ordered with complementary reference materials. View fixed-price bundles on Sales & Bundles.
Technical reference
Survodutide (BI-456906) is a dual GLP-1/glucagon receptor co-agonist with a structural design intended to balance incretin and glucagonergic signalling. Research interest centres on its effects in hepatic lipid metabolism, adipose browning, and energy expenditure models.
Supplied lyophilized at ≥98% HPLC purity with batch COA. Available as 10 mg.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| Storage | −20°C desiccated |
Research Use Only. Not for human or veterinary use.
| Vial size | 10mg |
|---|
COA and batch-specific data ship with materials when applicable. For retrievable archives, institutional PO references, or audit trails, contact procurement with your SKU and lot number.
Follow the product insert and COA for your lot. Lyophilized peptides are typically stored cold and protected from moisture until reconstitution in a controlled environment.
Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Review the published research use statement before purchasing.
Catalog
